Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 21 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		A Phase I/II Study of the Photon Radiosurgery System

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				2 to 32				Other				CNS 0201 NCT00179907


2.		Intracerebral Clysis in Treating Patients With Recurrent Primary Brain Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				1 to 120				Other				R01 CA 89395-01 Topotecan, Brain Tumors, Intracerebral Clysis, NCT00452959

Last Modified: 10/22/2008 First Published: 11/1/1998


3.		Phase II Study of Antineoplastons A10 and AS2-1 in Patients With Severe Brain Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Other				BC-BT-9 NCT00003457


4.		Exploratory Study, Evaluating the Treatment Effect of Surgery Plus GLIADEL® Wafer in Patients With Metastatic Brain Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Pharmaceutical / Industry				GLIA-001 NCT00525590


5.		Tumor Lysate Pulsed Dendritic Cell Immunotherapy for Patients With Brain Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				Not specified				Other				3368 NCT00576537


6.		Phase II Imatinib + Hydroxyurea in Treatment of Patients With Recurrent/Progressive Grade II Low-Grade Glioma (LGG)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Other				7262-07-7R2 NCT00615927

Last Modified: 9/8/2008


7.		Phase I Study of Photodynamic Therapy With Benzoporphyrin Derivative Monoacid Ring A in Patients With Refractory Brain Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Active				3 to 70				Other				MCW-7594 MCW-CHW-511, MCW-CHW-9411, NCI-V95-0652, NCT00002647

Last Modified: 8/16/2008 First Published: 11/4/2005


8.		Phase I Study of Intra-Arterial Melphalan and Mannitol in Patients With Central Nervous System Malignancies

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Active				18 months and over				NCI				OHSU-1299 OHSU-ONC-98018-L, OHSU-4834, NCT00253721


9.		A Trial Using Velcade Plus Chemoradiation for Central Nervous System, Head and Neck, and Cervical Cancer Patients

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Active				18 and over				Other				05C.255 NCT00329589


10.		Phase I Study Using Sunitinib Plus Radiation Therapy for Cancer Patients

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Active				18 and over				Other				06C.549 NCT00437372

Select All on One Page


					1 2 3 Next >

| | | | | | | |

A Service of the National Cancer Institute